| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelium, Vascular | 69 | 2019 | 4420 | 5.150 |
Why?
|
| Endothelial Cells | 51 | 2019 | 3551 | 3.480 |
Why?
|
| von Willebrand Factor | 17 | 2019 | 677 | 2.450 |
Why?
|
| Promoter Regions, Genetic | 35 | 2020 | 5773 | 1.850 |
Why?
|
| Hemostasis | 12 | 2022 | 470 | 1.580 |
Why?
|
| Thrombin | 12 | 2009 | 593 | 1.540 |
Why?
|
| Sepsis | 23 | 2019 | 2585 | 1.470 |
Why?
|
| Gene Expression Regulation | 35 | 2019 | 11856 | 1.320 |
Why?
|
| Endothelium | 7 | 2011 | 763 | 1.280 |
Why?
|
| Hagfishes | 4 | 2017 | 12 | 1.260 |
Why?
|
| Vascular Endothelial Growth Factor A | 21 | 2017 | 3493 | 1.250 |
Why?
|
| Receptors, Cell Surface | 11 | 2019 | 2802 | 1.170 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 14 | 2020 | 691 | 1.160 |
Why?
|
| Blood Vessels | 7 | 2015 | 1111 | 1.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 10 | 2017 | 558 | 1.010 |
Why?
|
| Blood Coagulation | 10 | 2018 | 1156 | 0.930 |
Why?
|
| Forkhead Transcription Factors | 10 | 2015 | 1613 | 0.900 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 8 | 2014 | 69 | 0.880 |
Why?
|
| Transcription Factors | 26 | 2018 | 12099 | 0.840 |
Why?
|
| Capillaries | 6 | 2016 | 755 | 0.820 |
Why?
|
| Immediate-Early Proteins | 6 | 2003 | 444 | 0.800 |
Why?
|
| Biological Evolution | 5 | 2013 | 1075 | 0.760 |
Why?
|
| Thrombosis | 12 | 2022 | 2944 | 0.730 |
Why?
|
| Multiple Organ Failure | 4 | 2010 | 386 | 0.710 |
Why?
|
| Umbilical Veins | 15 | 2009 | 423 | 0.710 |
Why?
|
| RNA, Messenger | 28 | 2019 | 12747 | 0.670 |
Why?
|
| DNA-Binding Proteins | 21 | 2018 | 9566 | 0.660 |
Why?
|
| Lipopolysaccharides | 13 | 2019 | 2199 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-akt | 8 | 2014 | 2455 | 0.640 |
Why?
|
| Cells, Cultured | 40 | 2019 | 18926 | 0.630 |
Why?
|
| Signal Transduction | 31 | 2019 | 23416 | 0.590 |
Why?
|
| Neovascularization, Pathologic | 10 | 2019 | 2636 | 0.580 |
Why?
|
| Animals | 103 | 2024 | 168079 | 0.540 |
Why?
|
| Neovascularization, Physiologic | 6 | 2014 | 1347 | 0.530 |
Why?
|
| Megakaryocytes | 6 | 2024 | 566 | 0.510 |
Why?
|
| Thrombomodulin | 6 | 2017 | 105 | 0.490 |
Why?
|
| NF-kappa B | 7 | 2017 | 2475 | 0.460 |
Why?
|
| Gene Expression | 10 | 2017 | 7571 | 0.460 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 318 | 0.450 |
Why?
|
| Phenotype | 19 | 2016 | 16575 | 0.450 |
Why?
|
| Mice, Transgenic | 27 | 2019 | 9520 | 0.450 |
Why?
|
| Epidermal Growth Factor | 3 | 2001 | 699 | 0.450 |
Why?
|
| Blood Coagulation Factors | 2 | 2015 | 366 | 0.450 |
Why?
|
| Protein Modification, Translational | 1 | 2013 | 21 | 0.430 |
Why?
|
| Nuclear Proteins | 7 | 2010 | 5782 | 0.430 |
Why?
|
| Lac Operon | 7 | 2013 | 237 | 0.430 |
Why?
|
| Blood Coagulation Disorders | 3 | 2020 | 350 | 0.420 |
Why?
|
| Shock, Septic | 3 | 2018 | 769 | 0.420 |
Why?
|
| Receptor, TIE-2 | 5 | 2013 | 176 | 0.420 |
Why?
|
| Inflammation | 15 | 2019 | 10759 | 0.410 |
Why?
|
| Mice | 65 | 2024 | 81326 | 0.410 |
Why?
|
| GA-Binding Protein Transcription Factor | 3 | 2011 | 43 | 0.400 |
Why?
|
| Vascular Diseases | 3 | 2010 | 1160 | 0.400 |
Why?
|
| Aorta | 6 | 2016 | 2040 | 0.400 |
Why?
|
| Mosaicism | 1 | 2016 | 477 | 0.400 |
Why?
|
| Malaria, Cerebral | 1 | 2013 | 136 | 0.400 |
Why?
|
| Endotoxemia | 6 | 2019 | 196 | 0.390 |
Why?
|
| Blood Circulation | 2 | 2011 | 248 | 0.390 |
Why?
|
| Cardiovascular System | 2 | 2011 | 836 | 0.390 |
Why?
|
| Dermis | 3 | 2013 | 202 | 0.380 |
Why?
|
| Tumor Necrosis Factor-alpha | 14 | 2020 | 4340 | 0.370 |
Why?
|
| Proteoglycans | 2 | 2006 | 803 | 0.370 |
Why?
|
| Thromboplastin | 4 | 2018 | 286 | 0.360 |
Why?
|
| Organ Specificity | 9 | 2019 | 1963 | 0.360 |
Why?
|
| Muscle, Smooth, Vascular | 4 | 2013 | 1488 | 0.360 |
Why?
|
| Nitric Oxide Synthase | 4 | 2005 | 908 | 0.360 |
Why?
|
| Endothelial Growth Factors | 4 | 2001 | 672 | 0.350 |
Why?
|
| Superoxide Dismutase | 2 | 2004 | 593 | 0.350 |
Why?
|
| Pregnancy Proteins | 2 | 2008 | 223 | 0.350 |
Why?
|
| Protein C | 3 | 2007 | 133 | 0.350 |
Why?
|
| Early Growth Response Protein 1 | 8 | 2009 | 133 | 0.350 |
Why?
|
| I-kappa B Proteins | 4 | 2006 | 210 | 0.340 |
Why?
|
| Cell Adhesion | 12 | 2018 | 3091 | 0.340 |
Why?
|
| Lymphokines | 4 | 2001 | 925 | 0.340 |
Why?
|
| Nonlinear Dynamics | 1 | 2012 | 492 | 0.340 |
Why?
|
| Muscle Proteins | 5 | 2013 | 1149 | 0.340 |
Why?
|
| Early Growth Response Transcription Factors | 1 | 2009 | 32 | 0.330 |
Why?
|
| Cloning, Molecular | 5 | 2018 | 4167 | 0.330 |
Why?
|
| GATA Transcription Factors | 1 | 2009 | 29 | 0.330 |
Why?
|
| Active Transport, Cell Nucleus | 8 | 2008 | 430 | 0.330 |
Why?
|
| CREB-Binding Protein | 1 | 2009 | 146 | 0.330 |
Why?
|
| Spleen | 3 | 2013 | 2290 | 0.320 |
Why?
|
| Erythropoiesis | 1 | 2013 | 683 | 0.320 |
Why?
|
| Humans | 140 | 2024 | 761208 | 0.310 |
Why?
|
| Platelet Factor 4 | 3 | 2013 | 129 | 0.310 |
Why?
|
| Kidney | 9 | 2019 | 7033 | 0.310 |
Why?
|
| RNA Splicing | 1 | 2013 | 896 | 0.310 |
Why?
|
| DNA Methylation | 5 | 2019 | 4384 | 0.300 |
Why?
|
| Thrombopoiesis | 2 | 2024 | 164 | 0.300 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2018 | 4513 | 0.300 |
Why?
|
| Leukocytes | 5 | 2019 | 2025 | 0.300 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 1112 | 0.290 |
Why?
|
| Muscle, Skeletal | 5 | 2014 | 4947 | 0.290 |
Why?
|
| Hyperhomocysteinemia | 1 | 2008 | 118 | 0.290 |
Why?
|
| Factor VIIa | 2 | 2018 | 103 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-ets | 4 | 2013 | 314 | 0.290 |
Why?
|
| Intercellular Adhesion Molecule-1 | 10 | 2013 | 1128 | 0.290 |
Why?
|
| Homeostasis | 5 | 2024 | 3320 | 0.280 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2008 | 270 | 0.280 |
Why?
|
| Physiology | 1 | 2007 | 110 | 0.280 |
Why?
|
| Mesenteric Arteries | 1 | 2007 | 178 | 0.280 |
Why?
|
| Models, Cardiovascular | 2 | 2015 | 983 | 0.270 |
Why?
|
| Neoplasms, Experimental | 3 | 2008 | 1225 | 0.270 |
Why?
|
| Cell Lineage | 3 | 2024 | 2548 | 0.270 |
Why?
|
| Thrombocytopenia | 4 | 2005 | 1182 | 0.270 |
Why?
|
| Transcriptional Activation | 8 | 2012 | 1749 | 0.260 |
Why?
|
| Chromatin Immunoprecipitation | 6 | 2016 | 848 | 0.260 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2014 | 698 | 0.260 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2007 | 241 | 0.260 |
Why?
|
| Erythropoietin | 3 | 2013 | 719 | 0.250 |
Why?
|
| Malaria, Falciparum | 1 | 2013 | 1076 | 0.250 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 2058 | 0.240 |
Why?
|
| Antigens, CD | 3 | 2019 | 4009 | 0.240 |
Why?
|
| Oxidation-Reduction | 3 | 2010 | 2227 | 0.240 |
Why?
|
| Hematologic Diseases | 3 | 2003 | 496 | 0.240 |
Why?
|
| Homocysteine | 1 | 2008 | 637 | 0.240 |
Why?
|
| RNA, Small Interfering | 9 | 2019 | 3412 | 0.240 |
Why?
|
| Transfection | 10 | 2014 | 5748 | 0.240 |
Why?
|
| Base Sequence | 9 | 2015 | 12404 | 0.240 |
Why?
|
| Models, Biological | 8 | 2012 | 9457 | 0.230 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 2015 | 1053 | 0.230 |
Why?
|
| Erythrocytes | 1 | 2013 | 2413 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2008 | 2864 | 0.230 |
Why?
|
| Myocardium | 8 | 2019 | 4746 | 0.230 |
Why?
|
| Platelet-Derived Growth Factor | 5 | 2005 | 617 | 0.230 |
Why?
|
| Environment | 1 | 2010 | 1122 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 23 | 2024 | 22127 | 0.220 |
Why?
|
| Trans-Activators | 6 | 2012 | 2846 | 0.220 |
Why?
|
| Monocytes | 7 | 2017 | 2570 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2013 | 2871 | 0.220 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 1740 | 0.220 |
Why?
|
| Heart | 6 | 2010 | 4431 | 0.220 |
Why?
|
| Serum Response Factor | 2 | 2009 | 78 | 0.220 |
Why?
|
| Receptors, Growth Factor | 3 | 2000 | 325 | 0.220 |
Why?
|
| Phosphorylation | 9 | 2008 | 8300 | 0.220 |
Why?
|
| Tunica Intima | 1 | 2005 | 458 | 0.210 |
Why?
|
| Vasodilation | 1 | 2007 | 966 | 0.210 |
Why?
|
| Gene Targeting | 3 | 2002 | 838 | 0.210 |
Why?
|
| Serum Response Element | 1 | 2002 | 7 | 0.210 |
Why?
|
| Gene Expression Profiling | 5 | 2019 | 9416 | 0.210 |
Why?
|
| Enzyme Induction | 3 | 2014 | 452 | 0.210 |
Why?
|
| Protein Binding | 8 | 2018 | 9297 | 0.200 |
Why?
|
| Microcirculation | 4 | 2018 | 1280 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type III | 5 | 2014 | 705 | 0.200 |
Why?
|
| Pneumonia | 2 | 2011 | 2142 | 0.200 |
Why?
|
| Atherosclerosis | 3 | 2008 | 3406 | 0.190 |
Why?
|
| Genes, Reporter | 8 | 2010 | 1518 | 0.190 |
Why?
|
| Reactive Oxygen Species | 6 | 2010 | 2138 | 0.190 |
Why?
|
| Lampreys | 2 | 2018 | 32 | 0.190 |
Why?
|
| Receptor Cross-Talk | 2 | 2017 | 115 | 0.190 |
Why?
|
| Cattle | 6 | 2013 | 3818 | 0.190 |
Why?
|
| GATA2 Transcription Factor | 5 | 2009 | 158 | 0.190 |
Why?
|
| beta-Galactosidase | 7 | 2004 | 574 | 0.180 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2014 | 3596 | 0.180 |
Why?
|
| Database Management Systems | 1 | 2002 | 256 | 0.180 |
Why?
|
| NFATC Transcription Factors | 4 | 2013 | 390 | 0.180 |
Why?
|
| Cell Line | 14 | 2017 | 15545 | 0.180 |
Why?
|
| E-Selectin | 5 | 2013 | 577 | 0.180 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 4 | 2015 | 664 | 0.180 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 4 | 2013 | 278 | 0.180 |
Why?
|
| Epigenesis, Genetic | 4 | 2020 | 3788 | 0.180 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2001 | 242 | 0.170 |
Why?
|
| Computational Biology | 1 | 2012 | 3499 | 0.170 |
Why?
|
| Early Growth Response Protein 3 | 2 | 2009 | 10 | 0.170 |
Why?
|
| Microvessels | 3 | 2013 | 580 | 0.170 |
Why?
|
| Protein Transport | 3 | 2017 | 1958 | 0.170 |
Why?
|
| Amino Acid Motifs | 4 | 2003 | 924 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 619 | 0.170 |
Why?
|
| Structure-Activity Relationship | 3 | 2018 | 3057 | 0.170 |
Why?
|
| Down-Regulation | 8 | 2013 | 2916 | 0.170 |
Why?
|
| Ribonucleases | 4 | 2005 | 264 | 0.170 |
Why?
|
| Cell Communication | 5 | 2017 | 1651 | 0.170 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 436 | 0.170 |
Why?
|
| Binding Sites | 7 | 2014 | 5988 | 0.170 |
Why?
|
| History, 17th Century | 2 | 2011 | 108 | 0.170 |
Why?
|
| Coronary Vessels | 10 | 2012 | 3111 | 0.170 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 4 | 2000 | 1624 | 0.160 |
Why?
|
| Lung | 8 | 2019 | 9979 | 0.160 |
Why?
|
| Protein Kinase C | 2 | 2008 | 1202 | 0.160 |
Why?
|
| Evolution, Molecular | 2 | 2018 | 1882 | 0.160 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2019 | 44 | 0.160 |
Why?
|
| Mice, Knockout | 10 | 2019 | 14392 | 0.160 |
Why?
|
| Introns | 2 | 2013 | 968 | 0.160 |
Why?
|
| Transcription Factor RelA | 4 | 2020 | 254 | 0.160 |
Why?
|
| Blotting, Northern | 4 | 2006 | 1545 | 0.160 |
Why?
|
| Oncogene Proteins | 3 | 2012 | 718 | 0.160 |
Why?
|
| Receptors, Immunologic | 2 | 2017 | 1408 | 0.160 |
Why?
|
| Molecular Biology | 1 | 2002 | 573 | 0.150 |
Why?
|
| Solubility | 3 | 2009 | 1085 | 0.150 |
Why?
|
| Exons | 4 | 2013 | 2380 | 0.150 |
Why?
|
| Thrombelastography | 1 | 2020 | 187 | 0.150 |
Why?
|
| Pulmonary Artery | 5 | 2016 | 1929 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factors | 5 | 2010 | 748 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2002 | 830 | 0.150 |
Why?
|
| Fish Proteins | 1 | 2018 | 47 | 0.150 |
Why?
|
| Weibel-Palade Bodies | 1 | 2017 | 19 | 0.150 |
Why?
|
| Angiopoietin-2 | 2 | 2017 | 173 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4567 | 0.150 |
Why?
|
| Platelet Aggregation | 2 | 2019 | 771 | 0.150 |
Why?
|
| Transplantation, Homologous | 1 | 2006 | 4822 | 0.140 |
Why?
|
| Chromones | 4 | 2008 | 148 | 0.140 |
Why?
|
| Culture Media, Conditioned | 3 | 2006 | 522 | 0.140 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 2468 | 0.140 |
Why?
|
| Embryo, Mammalian | 5 | 2008 | 1668 | 0.140 |
Why?
|
| Tissue Distribution | 4 | 2013 | 2263 | 0.140 |
Why?
|
| Cecum | 2 | 2009 | 233 | 0.140 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 573 | 0.140 |
Why?
|
| Mixed Function Oxygenases | 1 | 2018 | 265 | 0.140 |
Why?
|
| Transcription, Genetic | 10 | 2011 | 7571 | 0.140 |
Why?
|
| Medicine | 1 | 2005 | 942 | 0.140 |
Why?
|
| Time Factors | 12 | 2014 | 39957 | 0.140 |
Why?
|
| Sp1 Transcription Factor | 3 | 2019 | 140 | 0.130 |
Why?
|
| Hepatocytes | 2 | 2013 | 1231 | 0.130 |
Why?
|
| Luciferases | 3 | 2002 | 710 | 0.130 |
Why?
|
| Molecular Sequence Data | 6 | 2009 | 17598 | 0.130 |
Why?
|
| Vertebrates | 1 | 2017 | 227 | 0.130 |
Why?
|
| Cardiology | 1 | 2007 | 1693 | 0.130 |
Why?
|
| Resuscitation | 2 | 2018 | 672 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 3 | 2008 | 318 | 0.130 |
Why?
|
| Protein Conformation | 3 | 2018 | 3933 | 0.130 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1304 | 0.130 |
Why?
|
| Heparin | 2 | 2003 | 1632 | 0.130 |
Why?
|
| Cricetulus | 1 | 2017 | 812 | 0.130 |
Why?
|
| Adenoviridae | 4 | 2014 | 1084 | 0.130 |
Why?
|
| Gene Regulatory Networks | 2 | 2016 | 1743 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 4404 | 0.120 |
Why?
|
| Databases, Genetic | 1 | 2002 | 1741 | 0.120 |
Why?
|
| Yolk Sac | 2 | 2014 | 79 | 0.120 |
Why?
|
| Transgenes | 4 | 2019 | 1008 | 0.120 |
Why?
|
| Peptide Fragments | 2 | 2007 | 5103 | 0.120 |
Why?
|
| Anticoagulants | 4 | 2020 | 4795 | 0.120 |
Why?
|
| Neoplasms | 4 | 2020 | 22140 | 0.120 |
Why?
|
| CHO Cells | 1 | 2017 | 1379 | 0.120 |
Why?
|
| Cell Cycle | 3 | 2016 | 2925 | 0.120 |
Why?
|
| Calcineurin | 2 | 2013 | 229 | 0.120 |
Why?
|
| Capillary Permeability | 3 | 2013 | 773 | 0.120 |
Why?
|
| Bone Marrow | 3 | 2024 | 2911 | 0.120 |
Why?
|
| Blood Platelets | 5 | 2024 | 2477 | 0.110 |
Why?
|
| Morpholines | 4 | 2008 | 581 | 0.110 |
Why?
|
| Blotting, Western | 5 | 2011 | 5032 | 0.110 |
Why?
|
| NIH 3T3 Cells | 1 | 2016 | 667 | 0.110 |
Why?
|
| DNA, Complementary | 1 | 2017 | 1989 | 0.110 |
Why?
|
| Neoplasm Proteins | 2 | 2006 | 3594 | 0.110 |
Why?
|
| Periodicals as Topic | 1 | 2005 | 1463 | 0.110 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2016 | 696 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2008 | 1900 | 0.110 |
Why?
|
| Interleukin-6 | 2 | 2017 | 3210 | 0.110 |
Why?
|
| Protein Folding | 1 | 2017 | 869 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-sis | 3 | 2005 | 254 | 0.110 |
Why?
|
| Hospital Mortality | 6 | 2017 | 5295 | 0.110 |
Why?
|
| Megakaryocyte Progenitor Cells | 1 | 2013 | 28 | 0.110 |
Why?
|
| DNA Replication Timing | 1 | 2013 | 35 | 0.110 |
Why?
|
| Dendritic Cells | 1 | 2024 | 2726 | 0.110 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 11067 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2015 | 506 | 0.110 |
Why?
|
| Blood Platelet Disorders | 1 | 2013 | 60 | 0.110 |
Why?
|
| Transforming Growth Factor beta | 1 | 2000 | 1963 | 0.100 |
Why?
|
| Simvastatin | 1 | 2015 | 346 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 163 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15841 | 0.100 |
Why?
|
| Down Syndrome | 4 | 2013 | 901 | 0.100 |
Why?
|
| Physiology, Comparative | 1 | 2012 | 8 | 0.100 |
Why?
|
| Biomedical Research | 2 | 2005 | 3434 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2016 | 577 | 0.100 |
Why?
|
| Osteopontin | 1 | 2014 | 302 | 0.100 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2013 | 122 | 0.100 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 2091 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 974 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2002 | 1240 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2011 | 3777 | 0.100 |
Why?
|
| Enzyme Inhibitors | 6 | 2014 | 3702 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 3 | 2013 | 292 | 0.100 |
Why?
|
| Acetophenones | 2 | 2002 | 52 | 0.100 |
Why?
|
| Cadherins | 3 | 2019 | 902 | 0.100 |
Why?
|
| Amino Acid Sequence | 3 | 2019 | 13402 | 0.100 |
Why?
|
| Renal Veins | 1 | 2012 | 102 | 0.100 |
Why?
|
| S Phase | 1 | 2013 | 423 | 0.100 |
Why?
|
| Hemorrhage | 2 | 2020 | 3422 | 0.100 |
Why?
|
| DNA Footprinting | 2 | 2002 | 97 | 0.100 |
Why?
|
| Gene Knock-In Techniques | 1 | 2013 | 420 | 0.100 |
Why?
|
| Male | 35 | 2024 | 360693 | 0.100 |
Why?
|
| History, 16th Century | 1 | 2011 | 70 | 0.090 |
Why?
|
| Endocardium | 1 | 2012 | 248 | 0.090 |
Why?
|
| Macrophage Activation | 1 | 2014 | 552 | 0.090 |
Why?
|
| Shock, Hemorrhagic | 1 | 2013 | 223 | 0.090 |
Why?
|
| Cell Division | 4 | 2016 | 4451 | 0.090 |
Why?
|
| Culture Media | 2 | 2005 | 894 | 0.090 |
Why?
|
| Arterioles | 1 | 2012 | 250 | 0.090 |
Why?
|
| Disease Models, Animal | 9 | 2019 | 18220 | 0.090 |
Why?
|
| Claudins | 1 | 2012 | 117 | 0.090 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2013 | 355 | 0.090 |
Why?
|
| History, Ancient | 1 | 2011 | 213 | 0.090 |
Why?
|
| STAT6 Transcription Factor | 1 | 2011 | 196 | 0.090 |
Why?
|
| Heart Valves | 1 | 2012 | 284 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2013 | 546 | 0.090 |
Why?
|
| Heart Failure | 2 | 2014 | 11701 | 0.090 |
Why?
|
| Mutation | 7 | 2013 | 30002 | 0.090 |
Why?
|
| Cryopreservation | 2 | 2014 | 728 | 0.090 |
Why?
|
| Dimerization | 2 | 2002 | 887 | 0.090 |
Why?
|
| Rats | 8 | 2011 | 23704 | 0.090 |
Why?
|
| Models, Genetic | 2 | 2016 | 3430 | 0.090 |
Why?
|
| Renal Artery | 1 | 2012 | 351 | 0.090 |
Why?
|
| NFI Transcription Factors | 1 | 2010 | 42 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2005 | 10756 | 0.090 |
Why?
|
| DNA Primers | 3 | 2008 | 2814 | 0.090 |
Why?
|
| Embryonic Development | 2 | 2010 | 719 | 0.080 |
Why?
|
| Systems Biology | 1 | 2013 | 481 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 2509 | 0.080 |
Why?
|
| Serpins | 2 | 2009 | 247 | 0.080 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2011 | 275 | 0.080 |
Why?
|
| Kidney Glomerulus | 1 | 2012 | 567 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1967 | 0.080 |
Why?
|
| Serpin E2 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Mesoderm | 1 | 2012 | 673 | 0.080 |
Why?
|
| Physicians | 1 | 2007 | 4584 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2014 | 1200 | 0.080 |
Why?
|
| Research Design | 1 | 2005 | 6180 | 0.080 |
Why?
|
| Blood Coagulation Tests | 1 | 2010 | 271 | 0.080 |
Why?
|
| Wounds, Stab | 1 | 2009 | 72 | 0.080 |
Why?
|
| Flow Cytometry | 3 | 2016 | 5871 | 0.080 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2011 | 790 | 0.080 |
Why?
|
| Cell Nucleus | 4 | 2008 | 2881 | 0.080 |
Why?
|
| GATA3 Transcription Factor | 1 | 2009 | 155 | 0.080 |
Why?
|
| Species Specificity | 1 | 2013 | 2406 | 0.080 |
Why?
|
| Arteries | 2 | 2005 | 1121 | 0.080 |
Why?
|
| Antimicrobial Cationic Peptides | 2 | 2001 | 352 | 0.080 |
Why?
|
| Female | 28 | 2024 | 392544 | 0.080 |
Why?
|
| Embryonic Stem Cells | 2 | 2014 | 1246 | 0.080 |
Why?
|
| Blood | 1 | 1991 | 596 | 0.080 |
Why?
|
| Inositol | 1 | 2009 | 215 | 0.080 |
Why?
|
| Neutrophils | 4 | 2009 | 3763 | 0.080 |
Why?
|
| Emergency Service, Hospital | 4 | 2020 | 7865 | 0.080 |
Why?
|
| Ligation | 1 | 2009 | 446 | 0.080 |
Why?
|
| Macrophages | 3 | 2014 | 5753 | 0.070 |
Why?
|
| Heart Transplantation | 3 | 2004 | 3258 | 0.070 |
Why?
|
| Genes | 1 | 2012 | 1820 | 0.070 |
Why?
|
| Lung Transplantation | 1 | 1997 | 1307 | 0.070 |
Why?
|
| Bone Marrow Cells | 2 | 2013 | 2410 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2000 | 517 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 3726 | 0.070 |
Why?
|
| Gene Transfer Techniques | 3 | 2003 | 1201 | 0.070 |
Why?
|
| Up-Regulation | 3 | 2008 | 4111 | 0.070 |
Why?
|
| Apoptosis | 6 | 2024 | 9477 | 0.070 |
Why?
|
| APACHE | 1 | 2008 | 267 | 0.070 |
Why?
|
| Protein Isoforms | 2 | 2019 | 1695 | 0.070 |
Why?
|
| Models, Molecular | 1 | 2017 | 5406 | 0.070 |
Why?
|
| Hypokalemia | 1 | 1988 | 153 | 0.070 |
Why?
|
| Patient Discharge | 1 | 2020 | 3441 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 174 | 0.070 |
Why?
|
| Hirudins | 1 | 2008 | 179 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2011 | 1154 | 0.070 |
Why?
|
| Bradykinin | 1 | 2007 | 205 | 0.070 |
Why?
|
| History, 18th Century | 1 | 2007 | 206 | 0.070 |
Why?
|
| Cell Differentiation | 5 | 2014 | 11509 | 0.070 |
Why?
|
| Prospective Studies | 9 | 2019 | 54435 | 0.070 |
Why?
|
| Carbon Dioxide | 1 | 1991 | 1147 | 0.070 |
Why?
|
| Phenylephrine | 1 | 2007 | 294 | 0.070 |
Why?
|
| Hyperglycemia | 2 | 2012 | 1375 | 0.070 |
Why?
|
| P-Selectin | 1 | 2009 | 599 | 0.070 |
Why?
|
| Venules | 1 | 2006 | 161 | 0.070 |
Why?
|
| Hyperplasia | 2 | 2010 | 1150 | 0.070 |
Why?
|
| Histone Deacetylases | 2 | 2008 | 716 | 0.070 |
Why?
|
| Gene Deletion | 2 | 2006 | 2658 | 0.070 |
Why?
|
| Adenosine Diphosphate | 1 | 2007 | 422 | 0.070 |
Why?
|
| Neutrophil Infiltration | 1 | 2008 | 390 | 0.070 |
Why?
|
| Adiponectin | 1 | 2012 | 1107 | 0.070 |
Why?
|
| RNA | 4 | 2006 | 2709 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2009 | 696 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 1852 | 0.060 |
Why?
|
| Hyponatremia | 1 | 1988 | 280 | 0.060 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2013 | 680 | 0.060 |
Why?
|
| Phylogeny | 1 | 2013 | 2809 | 0.060 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 900 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 4 | 2013 | 1067 | 0.060 |
Why?
|
| Hypotension | 1 | 2011 | 879 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2013 | 1405 | 0.060 |
Why?
|
| Diabetes Complications | 1 | 2012 | 1316 | 0.060 |
Why?
|
| Cytoplasm | 2 | 2010 | 1498 | 0.060 |
Why?
|
| Immunoconjugates | 1 | 2013 | 963 | 0.060 |
Why?
|
| YY1 Transcription Factor | 2 | 2019 | 60 | 0.060 |
Why?
|
| Middle Aged | 18 | 2020 | 220853 | 0.060 |
Why?
|
| Acetylcholine | 1 | 2007 | 629 | 0.060 |
Why?
|
| Aged | 16 | 2020 | 169288 | 0.060 |
Why?
|
| History, 19th Century | 1 | 2007 | 718 | 0.060 |
Why?
|
| Sulfones | 2 | 2013 | 448 | 0.060 |
Why?
|
| Internal Medicine | 1 | 2012 | 1050 | 0.060 |
Why?
|
| Diabetes Mellitus | 3 | 2014 | 5842 | 0.060 |
Why?
|
| PubMed | 1 | 2005 | 129 | 0.060 |
Why?
|
| Oxygen Consumption | 1 | 1991 | 1867 | 0.060 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 2009 | 501 | 0.060 |
Why?
|
| Mice, 129 Strain | 2 | 2016 | 370 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 752 | 0.060 |
Why?
|
| Lectins | 1 | 2006 | 489 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2012 | 1681 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2008 | 1651 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 1992 | 2692 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2005 | 2803 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 2008 | 1250 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2004 | 227 | 0.060 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2005 | 325 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 1762 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 4739 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 3388 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 655 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2005 | 704 | 0.050 |
Why?
|
| Receptors, Thrombin | 1 | 2003 | 130 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2000 | 2665 | 0.050 |
Why?
|
| Carrier Proteins | 2 | 2008 | 4935 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 3446 | 0.050 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2002 | 21 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 989 | 0.050 |
Why?
|
| Benzopyrans | 1 | 2002 | 63 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2006 | 643 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2002 | 114 | 0.050 |
Why?
|
| Drug Design | 2 | 2013 | 1045 | 0.050 |
Why?
|
| Culture Media, Serum-Free | 1 | 2002 | 148 | 0.050 |
Why?
|
| DNA | 3 | 2007 | 7189 | 0.050 |
Why?
|
| Cell Movement | 4 | 2014 | 5195 | 0.050 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2002 | 92 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2006 | 1080 | 0.050 |
Why?
|
| Genes, Synthetic | 1 | 2002 | 88 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2024 | 10422 | 0.050 |
Why?
|
| Feedback, Physiological | 1 | 2024 | 475 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 2 | 2001 | 551 | 0.050 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2047 | 0.050 |
Why?
|
| Financing, Government | 1 | 2005 | 472 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2012 | 2756 | 0.050 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2006 | 774 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 793 | 0.050 |
Why?
|
| Models, Anatomic | 1 | 2005 | 683 | 0.050 |
Why?
|
| Shock | 1 | 2003 | 314 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2011 | 6067 | 0.050 |
Why?
|
| Catalase | 1 | 2001 | 217 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2007 | 1567 | 0.050 |
Why?
|
| Multienzyme Complexes | 2 | 2001 | 665 | 0.050 |
Why?
|
| Blood Physiological Phenomena | 1 | 2000 | 53 | 0.050 |
Why?
|
| Genotype | 2 | 2012 | 12985 | 0.050 |
Why?
|
| Veins | 1 | 2005 | 767 | 0.050 |
Why?
|
| Xanthine Oxidase | 1 | 2000 | 69 | 0.050 |
Why?
|
| Infarction | 1 | 2002 | 248 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 403 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 2001 | 211 | 0.040 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 332 | 0.040 |
Why?
|
| Plasmids | 2 | 2006 | 2261 | 0.040 |
Why?
|
| Critical Illness | 1 | 2013 | 2724 | 0.040 |
Why?
|
| Caspases | 1 | 2003 | 878 | 0.040 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 1885 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2000 | 260 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2004 | 965 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 8164 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 2000 | 362 | 0.040 |
Why?
|
| Kinetics | 3 | 2016 | 6312 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3245 | 0.040 |
Why?
|
| Mitoxantrone | 1 | 2000 | 148 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2002 | 850 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 413 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6223 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2009 | 1334 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 2381 | 0.040 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 1249 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2019 | 656 | 0.040 |
Why?
|
| Clone Cells | 2 | 2000 | 1668 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 8530 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 636 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2013 | 4744 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 251 | 0.040 |
Why?
|
| Allopurinol | 1 | 2000 | 198 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2007 | 2765 | 0.040 |
Why?
|
| Viscera | 1 | 2019 | 138 | 0.040 |
Why?
|
| Peptides | 2 | 2002 | 4353 | 0.040 |
Why?
|
| Response Elements | 1 | 2000 | 306 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2000 | 1083 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 471 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 1791 | 0.040 |
Why?
|
| GATA6 Transcription Factor | 1 | 2019 | 50 | 0.040 |
Why?
|
| Interleukin-17 | 1 | 2005 | 913 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 475 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2002 | 927 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 2014 | 3388 | 0.040 |
Why?
|
| Enzyme Activation | 3 | 2013 | 3577 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2018 | 41496 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4107 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 588 | 0.040 |
Why?
|
| Injections, Intravenous | 2 | 2017 | 1376 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2004 | 1251 | 0.040 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2001 | 480 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 2018 | 241 | 0.040 |
Why?
|
| Cytarabine | 1 | 2000 | 697 | 0.040 |
Why?
|
| Calcium | 2 | 2010 | 5719 | 0.040 |
Why?
|
| Liver | 2 | 2006 | 7514 | 0.040 |
Why?
|
| Morphogenesis | 2 | 2012 | 741 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 874 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2002 | 1487 | 0.040 |
Why?
|
| Prothrombin Time | 1 | 2018 | 117 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2009 | 2426 | 0.040 |
Why?
|
| Fever | 1 | 2005 | 1618 | 0.040 |
Why?
|
| Adult | 12 | 2020 | 221119 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2012 | 6392 | 0.040 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 1933 | 0.040 |
Why?
|
| Ribosomal Proteins | 1 | 2019 | 370 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2002 | 1838 | 0.040 |
Why?
|
| Biopsy | 1 | 2009 | 6781 | 0.030 |
Why?
|
| Genome, Human | 1 | 2010 | 4423 | 0.030 |
Why?
|
| Hepatectomy | 1 | 2000 | 557 | 0.030 |
Why?
|
| Point Mutation | 1 | 2002 | 1593 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2012 | 1602 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2000 | 630 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2008 | 2974 | 0.030 |
Why?
|
| Melanoma | 2 | 2013 | 5694 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 1168 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 1998 | 217 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1129 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2018 | 424 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1303 | 0.030 |
Why?
|
| Ribosomes | 1 | 2019 | 494 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2003 | 1798 | 0.030 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2000 | 646 | 0.030 |
Why?
|
| Critical Care | 2 | 2012 | 2696 | 0.030 |
Why?
|
| Coronary Thrombosis | 1 | 1999 | 440 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2019 | 4137 | 0.030 |
Why?
|
| Recombinant Proteins | 3 | 2013 | 6504 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 2013 | 5809 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2013 | 9187 | 0.030 |
Why?
|
| G2 Phase | 1 | 2016 | 136 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2020 | 537 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2018 | 346 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1996 | 420 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 14025 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 1480 | 0.030 |
Why?
|
| Cell Survival | 3 | 2014 | 5778 | 0.030 |
Why?
|
| Stem Cells | 2 | 2000 | 3517 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 427 | 0.030 |
Why?
|
| Permeability | 1 | 2017 | 721 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 2 | 2013 | 1603 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6124 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2018 | 1162 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 849 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2414 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2000 | 1967 | 0.030 |
Why?
|
| Mitochondria | 1 | 2007 | 3620 | 0.030 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1994 | 195 | 0.030 |
Why?
|
| TATA Box | 1 | 1994 | 127 | 0.030 |
Why?
|
| Risk | 2 | 2020 | 9616 | 0.030 |
Why?
|
| Incidence | 2 | 2020 | 21365 | 0.030 |
Why?
|
| DNA Modification Methylases | 1 | 2014 | 210 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2014 | 4243 | 0.030 |
Why?
|
| Freezing | 1 | 2014 | 311 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2004 | 3114 | 0.030 |
Why?
|
| Drug Repositioning | 1 | 2015 | 233 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 2002 | 2193 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 1994 | 296 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 2062 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 2000 | 1901 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2013 | 524 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2013 | 216 | 0.030 |
Why?
|
| Premedication | 1 | 2013 | 246 | 0.030 |
Why?
|
| Insulator Elements | 1 | 2012 | 27 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2024 | 3044 | 0.020 |
Why?
|
| Pregnancy | 2 | 2013 | 29893 | 0.020 |
Why?
|
| Oxygen | 1 | 2003 | 4227 | 0.020 |
Why?
|
| Maine | 1 | 2012 | 146 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 602 | 0.020 |
Why?
|
| Testis | 1 | 1995 | 781 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2012 | 5885 | 0.020 |
Why?
|
| Peptide Library | 1 | 2013 | 347 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2013 | 864 | 0.020 |
Why?
|
| Ligands | 2 | 2008 | 3264 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2001 | 1910 | 0.020 |
Why?
|
| beta-Globins | 1 | 2012 | 111 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1995 | 1073 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2012 | 195 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1997 | 1611 | 0.020 |
Why?
|
| Brain | 4 | 2019 | 27092 | 0.020 |
Why?
|
| Microdissection | 1 | 2011 | 151 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2017 | 1162 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2014 | 543 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2013 | 1059 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 1855 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2014 | 1498 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 374 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2010 | 166 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2017 | 2359 | 0.020 |
Why?
|
| Pyrazoles | 2 | 2013 | 2010 | 0.020 |
Why?
|
| Platelet Count | 1 | 2013 | 782 | 0.020 |
Why?
|
| Peroxidase | 2 | 2005 | 610 | 0.020 |
Why?
|
| U937 Cells | 1 | 2010 | 260 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 16952 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 8003 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 634 | 0.020 |
Why?
|
| Academies and Institutes | 1 | 2012 | 318 | 0.020 |
Why?
|
| Ions | 1 | 2010 | 255 | 0.020 |
Why?
|
| Catechols | 1 | 2009 | 62 | 0.020 |
Why?
|
| Neointima | 1 | 2010 | 133 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2000 | 2133 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2009 | 122 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2013 | 790 | 0.020 |
Why?
|
| Leukocyte Rolling | 1 | 2008 | 69 | 0.020 |
Why?
|
| Cell Death | 1 | 2014 | 1676 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2001 | 2795 | 0.020 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2010 | 323 | 0.020 |
Why?
|
| Histones | 1 | 2019 | 2570 | 0.020 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 58952 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2010 | 565 | 0.020 |
Why?
|
| Biological Transport | 1 | 2013 | 2080 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2451 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2008 | 63 | 0.020 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 500 | 0.020 |
Why?
|
| Skin | 1 | 2002 | 4473 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2018 | 4165 | 0.020 |
Why?
|
| Nitriles | 1 | 2013 | 971 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2013 | 1329 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 2008 | 641 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2002 | 5921 | 0.020 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2007 | 89 | 0.020 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2008 | 123 | 0.020 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2008 | 379 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 1997 | 2725 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 1002 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3634 | 0.020 |
Why?
|
| Thiazolidinediones | 1 | 2010 | 460 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 931 | 0.020 |
Why?
|
| Calmodulin | 1 | 2008 | 217 | 0.020 |
Why?
|
| Hospitalization | 2 | 2020 | 10707 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 856 | 0.020 |
Why?
|
| Lasers | 1 | 2011 | 952 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 2571 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 2012 | 1169 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2007 | 109 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 12976 | 0.020 |
Why?
|
| Leupeptins | 1 | 2006 | 112 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 7400 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2010 | 896 | 0.020 |
Why?
|
| Peritonitis | 1 | 2008 | 368 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2015 | 2046 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2008 | 753 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1991 | 2477 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 388 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 1130 | 0.020 |
Why?
|
| Heart Rate | 1 | 1998 | 4197 | 0.020 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 1991 | 686 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2015 | 1935 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2008 | 335 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 1728 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2013 | 1662 | 0.020 |
Why?
|
| Ischemia | 1 | 2014 | 1889 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 29687 | 0.020 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2005 | 23 | 0.020 |
Why?
|
| Chickens | 1 | 2007 | 857 | 0.020 |
Why?
|
| Diuretics | 1 | 1988 | 611 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80674 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2011 | 3605 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2009 | 1217 | 0.010 |
Why?
|
| Azepines | 1 | 2006 | 328 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14675 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2001 | 1318 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2000 | 3609 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 1125 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2005 | 380 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2010 | 15520 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2011 | 883 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 2002 | 11476 | 0.010 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 1 | 2003 | 46 | 0.010 |
Why?
|
| Vaccinia | 1 | 2004 | 70 | 0.010 |
Why?
|
| Anoikis | 1 | 2003 | 50 | 0.010 |
Why?
|
| Hydroxamic Acids | 1 | 2006 | 479 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3803 | 0.010 |
Why?
|
| Interleukin-23 | 1 | 2005 | 201 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2012 | 2489 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2003 | 184 | 0.010 |
Why?
|
| GATA4 Transcription Factor | 1 | 2004 | 124 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2003 | 237 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2008 | 1682 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2003 | 190 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2001 | 7407 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2007 | 731 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1995 | 4201 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6345 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2012 | 2623 | 0.010 |
Why?
|
| Acute Disease | 1 | 2013 | 7226 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 578 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2004 | 329 | 0.010 |
Why?
|
| Trachea | 1 | 2008 | 1090 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2000 | 9278 | 0.010 |
Why?
|
| Growth Substances | 1 | 2003 | 759 | 0.010 |
Why?
|
| United States | 2 | 2010 | 72339 | 0.010 |
Why?
|
| Quinazolines | 1 | 2008 | 1371 | 0.010 |
Why?
|
| Manometry | 1 | 2003 | 453 | 0.010 |
Why?
|
| Pyridines | 1 | 2013 | 2872 | 0.010 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2003 | 165 | 0.010 |
Why?
|
| Forecasting | 1 | 2010 | 2928 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 74239 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 834 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2003 | 575 | 0.010 |
Why?
|
| RNA Interference | 1 | 2009 | 2816 | 0.010 |
Why?
|
| Pandemics | 1 | 2020 | 8663 | 0.010 |
Why?
|
| CpG Islands | 1 | 2005 | 1190 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2011 | 2092 | 0.010 |
Why?
|
| Interleukins | 1 | 2005 | 782 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2005 | 1243 | 0.010 |
Why?
|
| Antibodies | 1 | 2008 | 2415 | 0.010 |
Why?
|
| Autoantigens | 1 | 2004 | 888 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 1991 | 1640 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 3089 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2000 | 11733 | 0.010 |
Why?
|
| Boston | 1 | 2012 | 9327 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2000 | 193 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39126 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 20588 | 0.010 |
Why?
|
| Age Factors | 2 | 2009 | 18384 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 2004 | 1091 | 0.010 |
Why?
|
| Adolescent | 2 | 2020 | 88298 | 0.010 |
Why?
|
| Curriculum | 1 | 2012 | 3741 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 740 | 0.010 |
Why?
|
| Ubiquitins | 1 | 2000 | 366 | 0.010 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 1998 | 178 | 0.010 |
Why?
|
| Cerebellar Diseases | 1 | 2000 | 220 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 3885 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2010 | 9652 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 1721 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 12052 | 0.010 |
Why?
|
| Genomics | 1 | 2013 | 5828 | 0.010 |
Why?
|
| Insulin | 1 | 2012 | 6588 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2015 | 22174 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2000 | 13632 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2000 | 335 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 1996 | 45 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3778 | 0.010 |
Why?
|
| Comorbidity | 1 | 2011 | 10516 | 0.010 |
Why?
|
| Extraembryonic Membranes | 1 | 1996 | 38 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13249 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 1998 | 368 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3201 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 2635 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2000 | 619 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2008 | 3027 | 0.010 |
Why?
|
| Endoderm | 1 | 1996 | 160 | 0.010 |
Why?
|
| Exanthema | 1 | 2000 | 503 | 0.010 |
Why?
|
| Research | 1 | 2003 | 1976 | 0.010 |
Why?
|
| Neutropenia | 1 | 2000 | 885 | 0.010 |
Why?
|
| Trophoblasts | 1 | 1996 | 223 | 0.010 |
Why?
|
| Remission Induction | 1 | 2000 | 2392 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 15308 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 59221 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2444 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1998 | 1516 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 24021 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2000 | 1560 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 1518 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 2003 | 2493 | 0.010 |
Why?
|
| Survival Rate | 1 | 2005 | 12728 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 5909 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2000 | 6819 | 0.010 |
Why?
|
| Cause of Death | 1 | 2000 | 3688 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5250 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 2001 | 3899 | 0.000 |
Why?
|
| Placenta | 1 | 1996 | 1711 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10203 | 0.000 |
Why?
|
| Child | 1 | 1992 | 80152 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2000 | 64681 | 0.000 |
Why?
|